Gene: FAM91A1
Official Full Name: family with sequence similarity 91 member A1provided by HGNC
Gene Summary: Involved in intracellular protein transport and vesicle tethering to Golgi. Located in cytoplasmic vesicle and trans-Golgi network. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17822 | FAM91A1 Knockout cell line (HeLa) | Human | FAM91A1 | 1:3~1:6 | Negative | Online Inquiry |
KO17823 | FAM91A1 Knockout cell line (HCT 116) | Human | FAM91A1 | 1:2~1:4 | Negative | Online Inquiry |
KO17824 | FAM91A1 Knockout cell line (HEK293) | Human | FAM91A1 | 1:3~1:6 | Negative | Online Inquiry |
KO17825 | FAM91A1 Knockout cell line (A549) | Human | FAM91A1 | 1:3~1:4 | Negative | Online Inquiry |
FAM91A1 Gene Knockout Cell Lines represent a cutting-edge advancement in the field of genetic research, embodying a powerful tool for investigating the functional roles of the FAM91A1 gene. These cell lines are genetically engineered to express a complete knockout of the FAM91A1 gene, which encodes for a protein implicated in various cellular processes, including immune response modulation and cellular signaling pathways. By eliminating the expression of FAM91A1, researchers can elucidate the gene's role in pathophysiological conditions and identify its contribution to disease mechanisms.
The key function of FAM91A1 Gene Knockout Cell Lines lies in their ability to provide a controlled environment for studying gene function and interaction. By using CRISPR-Cas9 technology, these cell lines ensure precise gene editing, enabling researchers to observe phenotypic changes that result from the absence of FAM91A1. This elucidation can provide insights into its potential roles in cancer progression, autoimmune diseases, and other disorders where dysregulation of immune responses occurs.
From a scientific perspective, these knockout cell lines are invaluable in the realms of research and clinical applications. They are essential for validating the function of the FAM91A1 gene, paving the way for drug development and gene therapy strategies targeting associated pathways. This product enhances our understanding of the metabolic and regulatory networks involving FAM91A1, thereby facilitating the discovery of novel therapeutic targets.
Compared to traditional gene knockdown methods, such as siRNA or shRNA approaches, our FAM91A1 Gene Knockout Cell Lines offer superior specificity and stability, allowing for more reliable results over time. Additionally, the absence of off-target effects, common in other gene manipulation techniques, enhances the confidence in experimental outcomes.
Researchers and clinicians will find this product particularly valuable as it provides consistent and reproducible data essential for advancing basic and translational research. The integration of these cell lines into experimental designs can lead to significant breakthroughs with implications for therapeutic interventions.
With years of expertise in developing high-quality biological products, our company is dedicated to providing researchers with innovative tools that enhance scientific inquiry and support groundbreaking research endeavors. We are committed to driving progress in the life sciences and enabling our customers to achieve their research goals.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.